COVID-19 Resource Center for Infectious Disease Clinicians

The ever-evolving COVID-19 vaccination landscape has created many questions about who should receive additional vaccine doses, when, and why. Hear expert faculty discuss COVID-19 vaccination efficacy, the rationale for third doses and booster doses, and the data behind mixing and matching of booster doses.

Renslow Sherer, MD Released: December 10, 2021

Oral antiviral agents offer a new treatment option for nonhospitalized adult patients with COVID-19. Hear expert faculty discuss the safety and efficacy data of molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir in outpatient adults with mild to moderate COVID-19.

Renslow Sherer, MD Released: January 6, 2022

Do COVID-19 treatments retain their efficacy against the SARS-CoV-2 omicron variant? Hear expert faculty discuss the use of direct-acting, small-molecule antiviral agents and monoclonal antibodies during the omicron era.

Arthur Kim, MD Released: January 25, 2022

Transmissibility, disease severity, and vaccine effectiveness are different with the SARS-CoV-2 omicron variant compared with the ancestral virus and prior variants. Hear expert faculty discuss what we know about omicron.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: February 22, 2022

Long COVID is a syndrome that can occur in some patients following their COVID-19 infection. Hear expert faculty discuss what is known to date about long COVID, including potential causes, risk factors, signs and symptoms, and treatment strategies under consideration.

Renslow Sherer, MD Released: April 13, 2022

New data have emerged regarding treatment principles and therapeutic options for nonhospitalized adult and pediatric patients with COVID-19. Hear a faculty expert describe treatment options and treatments to avoid.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: May 24, 2022